Published • loading... • Updated
Oncovita Presents Promising Preclinical Data on MVdeltaC, a Novel Onco-Immunotherapy at EACR, 8-11 June 2026, in Budapest
Summary by The Manila Times
2 Articles
2 Articles
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
The full preclinical pharmacology package includes results from many solid tumors models including mesothelioma, bladder, triple negative breast cancer (TNBC) and neuroblastoma...
·Manila, Philippines (the)
Read Full Article
Coverage Details
Total News Sources2
Leaning Left1Leaning Right1Center0Last UpdatedBias Distribution50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
